Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

UPI fees mean different payoffs for Paytm & Pine

UPI fees will bring distinct benefits to Paytm and Pine Labs following the government's decision to monetize high-value UPI payments. Paytm is set to capture a larger share of the revenue, with analysts forecasting potential FY28 UPI MDR earnings of up to Rs 4.7 billion. Pine Labs, with a smaller UPI base, could see a 20% impact on EBIT and profit before tax.

The distinction in impact could influence how investors value both companies as the new framework comes into effect on October 15. The government has introduced a 40-basis-point merchant discount rate on UPI transactions above Rs 2,000, but most UPI transactions remain unaffected. The high-value segment, which accounted for just 4% of P2M transaction volumes in July, holds significant financial potential, with estimates ranging from Rs 15,000 crore to Rs 18,000 crore to be divided among various participants in the UPI ecosystem.

The exact allocation remains uncertain, adding a key variable to the revenue projections for both companies. Paytm's larger merchant network and consumer-facing UPI application position it to retain a significant portion of the MDR pool, potentially yielding around 8 basis points, while Pine Labs' exposure is more closely tied to acquiring and acceptance.

Analysts differ in their assumptions about eligible GMV and share retention, leading to varying valuations for the two companies. Paytm's large eligible GMV and higher potential uplift in adjusted EBITDA make it the larger value catalyst, while Pine Labs may experience a more immediate transformation in profitability.

Written by urgent.news from The Economic Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at economictimes.indiatimes.com →

More in Finance & Markets

More from Wednesday 16 September →